Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer

Clinical trial NCT00388960 · COMPLETED

Trial details

NCT number: NCT00388960
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer

Start date: 2006-11-01
Primary completion: 2010-04-01
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.